Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

IL-4/IL-13 Stimulated Macrophages Enhance Breast Cancer Invasion Via Rho-GTPase Regulation of Synergistic VEGF/CCL-18 Signaling.

Little AC, Pathanjeli P, Wu Z, Bao L, Goo LE, Yates JA, Oliver CR, Soellner MB, Merajver SD.

Front Oncol. 2019 May 31;9:456. doi: 10.3389/fonc.2019.00456. eCollection 2019.

2.

Virus-inclusive single-cell RNA sequencing reveals the molecular signature of progression to severe dengue.

Zanini F, Robinson ML, Croote D, Sahoo MK, Sanz AM, Ortiz-Lasso E, Albornoz LL, Rosso F, Montoya JG, Goo L, Pinsky BA, Quake SR, Einav S.

Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12363-E12369. doi: 10.1073/pnas.1813819115. Epub 2018 Dec 7.

3.

A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions.

Goo L, Debbink K, Kose N, Sapparapu G, Doyle MP, Wessel AW, Richner JM, Burgomaster KE, Larman BC, Dowd KA, Diamond MS, Crowe JE Jr, Pierson TC.

Nat Microbiol. 2019 Jan;4(1):71-77. doi: 10.1038/s41564-018-0283-7. Epub 2018 Nov 19.

4.

The Zika virus envelope protein glycan loop regulates virion antigenicity.

Goo L, DeMaso CR, Pelc RS, Ledgerwood JE, Graham BS, Kuhn RJ, Pierson TC.

Virology. 2018 Feb;515:191-202. doi: 10.1016/j.virol.2017.12.032. Epub 2018 Jan 2.

5.

A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis.

Goo L, VanBlargan LA, Dowd KA, Diamond MS, Pierson TC.

PLoS Pathog. 2017 Feb 16;13(2):e1006178. doi: 10.1371/journal.ppat.1006178. eCollection 2017 Feb.

6.

A Virus-Like Particle Vaccine Elicits Broad Neutralizing Antibody Responses in Humans to All Chikungunya Virus Genotypes.

Goo L, Dowd KA, Lin TY, Mascola JR, Graham BS, Ledgerwood JE, Pierson TC.

J Infect Dis. 2016 Nov 15;214(10):1487-1491. Epub 2016 Sep 21.

7.

Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity.

VanBlargan LA, Goo L, Pierson TC.

Microbiol Mol Biol Rev. 2016 Oct 26;80(4):989-1010. Print 2016 Dec. Review.

8.

Zika Virus Is Not Uniquely Stable at Physiological Temperatures Compared to Other Flaviviruses.

Goo L, Dowd KA, Smith AR, Pelc RS, DeMaso CR, Pierson TC.

MBio. 2016 Sep 6;7(5). pii: e01396-16. doi: 10.1128/mBio.01396-16.

9.

Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype.

Dowd KA, DeMaso CR, Pelc RS, Speer SD, Smith ARY, Goo L, Platt DJ, Mascola JR, Graham BS, Mulligan MJ, Diamond MS, Ledgerwood JE, Pierson TC.

Cell Rep. 2016 Aug 9;16(6):1485-1491. doi: 10.1016/j.celrep.2016.07.049. Epub 2016 Jul 29.

10.

Dengue virus: Bumps in the road to therapeutic antibodies.

Goo L, Pierson TC.

Nature. 2015 Aug 20;524(7565):295-6. doi: 10.1038/524295a. No abstract available.

PMID:
26289200
11.

HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers.

Sanders RW, van Gils MJ, Derking R, Sok D, Ketas TJ, Burger JA, Ozorowski G, Cupo A, Simonich C, Goo L, Arendt H, Kim HJ, Lee JH, Pugach P, Williams M, Debnath G, Moldt B, van Breemen MJ, Isik G, Medina-Ramírez M, Back JW, Koff WC, Julien JP, Rakasz EG, Seaman MS, Guttman M, Lee KK, Klasse PJ, LaBranche C, Schief WR, Wilson IA, Overbaugh J, Burton DR, Ward AB, Montefiori DC, Dean H, Moore JP.

Science. 2015 Jul 10;349(6244):aac4223. doi: 10.1126/science.aac4223. Epub 2015 Jun 18.

12.

Mutations in HIV-1 envelope that enhance entry with the macaque CD4 receptor alter antibody recognition by disrupting quaternary interactions within the trimer.

Boyd DF, Peterson D, Haggarty BS, Jordan AP, Hogan MJ, Goo L, Hoxie JA, Overbaugh J.

J Virol. 2015 Jan 15;89(2):894-907. doi: 10.1128/JVI.02680-14. Epub 2014 Nov 5.

13.

Early development of broadly neutralizing antibodies in HIV-1-infected infants.

Goo L, Chohan V, Nduati R, Overbaugh J.

Nat Med. 2014 Jun;20(6):655-8. doi: 10.1038/nm.3565. Epub 2014 May 25.

14.

HIV-1 maternal and infant variants show similar sensitivity to broadly neutralizing antibodies, but sensitivity varies by subtype.

Mabuka J, Goo L, Omenda MM, Nduati R, Overbaugh J.

AIDS. 2013 Jun 19;27(10):1535-44. doi: 10.1097/QAD.0b013e32835faba5.

15.

A combination of broadly neutralizing HIV-1 monoclonal antibodies targeting distinct epitopes effectively neutralizes variants found in early infection.

Goo L, Jalalian-Lechak Z, Richardson BA, Overbaugh J.

J Virol. 2012 Oct;86(19):10857-61. doi: 10.1128/JVI.01414-12. Epub 2012 Jul 25.

16.

Neutralizing antibody escape during HIV-1 mother-to-child transmission involves conformational masking of distal epitopes in envelope.

Goo L, Milligan C, Simonich CA, Nduati R, Overbaugh J.

J Virol. 2012 Sep;86(18):9566-82. doi: 10.1128/JVI.00953-12. Epub 2012 Jun 27.

17.

Intimate partner violence affects skilled attendance at most recent delivery among women in Kenya.

Goo L, Harlow SD.

Matern Child Health J. 2012 Jul;16(5):1131-7. doi: 10.1007/s10995-011-0838-1.

PMID:
21688110

Supplemental Content

Support Center